Compare JNJ & GGZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JNJ | GGZ |
|---|---|---|
| Founded | 1886 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 589.2B | 125.0M |
| IPO Year | 1944 | N/A |
| Metric | JNJ | GGZ |
|---|---|---|
| Price | $243.50 | $16.28 |
| Analyst Decision | Buy | |
| Analyst Count | 17 | 0 |
| Target Price | ★ $227.29 | N/A |
| AVG Volume (30 Days) | ★ 9.2M | 12.8K |
| Earning Date | 01-21-2026 | 01-01-0001 |
| Dividend Yield | 2.13% | ★ 5.39% |
| EPS Growth | ★ 71.26 | N/A |
| EPS | ★ 11.03 | 1.75 |
| Revenue | ★ $94,193,000,000.00 | N/A |
| Revenue This Year | $6.63 | N/A |
| Revenue Next Year | $7.21 | N/A |
| P/E Ratio | $22.17 | ★ $6.79 |
| Revenue Growth | ★ 5.08 | N/A |
| 52 Week Low | $141.50 | $9.43 |
| 52 Week High | $246.35 | $12.50 |
| Indicator | JNJ | GGZ |
|---|---|---|
| Relative Strength Index (RSI) | 83.07 | 66.34 |
| Support Level | $237.40 | $16.06 |
| Resistance Level | $246.35 | $16.40 |
| Average True Range (ATR) | 3.66 | 0.19 |
| MACD | 0.87 | 0.01 |
| Stochastic Oscillator | 90.12 | 84.22 |
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
The Gabelli Global Small and Mid Cap Value Trust is a diversified closed-ended management investment company whose investment objective is long-term capital growth. It invests in equity securities such as common stock and preferred stock of companies.